Abstract
Since late 1950s the main strategies to treat cancer, besides surgery, have been radiotherapy or chemotherapy. These approaches work primarily by damaging proliferating cells at the level of DNA replication or cell division, and inducing apoptotic cell suicide as a secondary response to the damage. In recent years, efforts to improve cancer therapy have focused on the development of more selective, biological mechanism based approaches that can help to overcome tumor resistance as well as minimize toxic side effects. In the present review new strategies and new targets for biological cancer therapy will be discussed. In particular, new angiogenic pathways discovered in melanoma will be discussed in relationship to a more efficient anticancer strategy. In summary, this review tries to identify the most logical targets and the most useful mechanisms of tumor inhibition in light of new knowledge from the basic research including human genome project.
Keywords: apoptosis, angiogenesis, vasculogenic mimicry
Current Drug Targets
Title: Cellular Targets for Anticancer Strategies
Volume: 5 Issue: 4
Author(s): Caterina A.M. La Porta
Affiliation:
Keywords: apoptosis, angiogenesis, vasculogenic mimicry
Abstract: Since late 1950s the main strategies to treat cancer, besides surgery, have been radiotherapy or chemotherapy. These approaches work primarily by damaging proliferating cells at the level of DNA replication or cell division, and inducing apoptotic cell suicide as a secondary response to the damage. In recent years, efforts to improve cancer therapy have focused on the development of more selective, biological mechanism based approaches that can help to overcome tumor resistance as well as minimize toxic side effects. In the present review new strategies and new targets for biological cancer therapy will be discussed. In particular, new angiogenic pathways discovered in melanoma will be discussed in relationship to a more efficient anticancer strategy. In summary, this review tries to identify the most logical targets and the most useful mechanisms of tumor inhibition in light of new knowledge from the basic research including human genome project.
Export Options
About this article
Cite this article as:
La Porta A.M. Caterina, Cellular Targets for Anticancer Strategies, Current Drug Targets 2004; 5 (4) . https://dx.doi.org/10.2174/1389450043345434
DOI https://dx.doi.org/10.2174/1389450043345434 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Surface Markers of Cancer Stem Cells in Solid Tumors
Current Stem Cell Research & Therapy Boron Containing Macromolecules and Nanovehicles as Delivery Agents for Neutron Capture Therapy†
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Antileukotriene Drug-<i>Camellia sinensis</i> Extract Co-Formulation on Histamine Induced Asthma in Guinea Pigs
Current Drug Research Reviews Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma
Current Radiopharmaceuticals Age-Related Changes in P-Glycoprotein Expression in Senescence- Accelerated Mouse
Current Aging Science Editorial (Thematic Issue: Improving Cancer Clinical Research and Trials with Hispanic Populations: Training and Outreach Efforts Between Moffitt Cancer Center and the Ponce School of Medicine)
Reviews on Recent Clinical Trials Imaging Requirements for Personalized Medicine: The Oncologists Point of View
Current Pharmaceutical Design Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases
Current Protein & Peptide Science Flavonoids as Anticancer Agents: Recent Progress and State of the Art?
Current Organic Chemistry Emergence in Pyrazolines: Synthetic and Biological Perspective
The Natural Products Journal Discovery of New Biomarkers of Cancer Using Proteomics Technology
Current Cancer Therapy Reviews Vitiligo: An Updated Narrative Review
Current Pediatric Reviews Protein Secretome Analysis of Evolving and Responding Tumor Ecosystems
Current Proteomics Novel Tyrosinase Inhibitors From Natural Resources – Their Computational Studies
Current Medicinal Chemistry Novel Therapeutic Approaches in Pancreatic Cancer Based on Genomic Alterations
Current Pharmaceutical Design Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?
Anti-Cancer Agents in Medicinal Chemistry Clinical Use of Therapies Targeting Tumor Vasculature and Stroma
Current Cancer Drug Targets Fragment Based Drug Design: From Experimental to Computational Approaches
Current Medicinal Chemistry